课题基金 / 基金详情

BILLARY ATRESIA (BA) CLINICAL RESEARCH-CORTICOSTEROID THERAPY IN INFANTS WITH BA

BILLARY ATRESIA (BA) CLINICAL RESEARCH-CORTICOSTEROID THERAPY IN INFANTS WITH BA
胆道闭锁 (BA) 临床研究 - BA 婴儿的皮质类固醇治疗
批准号:
7380583
负责人:
BENJAMIN L SHNEIDER
金额:
$1.29万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-17 至 2007-02-28

项目摘要

项目成果

BENJAMIN L SHNEIDER的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是利用由NIH/NCRR资助的中心拨款提供的资源的许多研究子项目之一。子项目和调查员(PI)可能从另一个NIH来源获得了主要资金,因此可能会出现在其他CRISE条目中。列出的机构是针对中心的,而不一定是针对调查员的机构。胆道闭锁是导致婴儿胆汁淤积(胆汁流动阻塞)的最常见原因,也是儿童肝移植最常见的适应症。这种疾病是由破坏性的炎症过程引起的,影响肝内外胆管,导致胆管纤维化和闭塞。虽然胆道闭锁的病因或发病机制知之甚少,但流行病学和病毒学研究指出,这是一种复杂的特质障碍,即环境因素引发炎症过程,在出生后发育的特定阶段识别并异常靶向胆道系统。不管疾病发展的始动(环境)和改变(遗传)因素,胆道上皮的炎性和纤维性破坏在所有临床形式的胆道闭锁中都是常见的。门肠吻合术(Kasai手术利用肠道制造人工胆管)是目前唯一用于改善胆道闭锁婴儿胆汁引流的手术方法。尽管及时的诊断和手术治疗可能会导致胆汁流动,但在2岁之前,超过50%的患者会进展为终末期肝病。在这种情况下,通过糖皮质激素治疗这种炎症成分的潜在减少可能导致胆汁流量的改善和门肠吻合术后更好的结果。我们提出了一项多中心随机、双盲、安慰剂对照试验,以前瞻性地确定皮质类固醇对胆道闭锁婴儿预后的疗效。这项试验将由NIDDK资助的由9个临床中心组成的网络进行,其中包括胆道闭锁临床研究联盟(BARC),其目标是研究婴儿胆道闭锁的病因、发病机制、诊断和治疗。假设:在这项临床试验中,我们建议客观地确定皮质类固醇治疗是否能改善胆道闭锁婴儿的胆汁流动。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Biliary atresia is the most common cause of cholestasis (bile flow blockage) in infants and the most frequent indication for pediatric liver transplantation. The disease results from a destructive inflammatory process that affects intra- and extrahepatic bile ducts, leading to fibrosis and obliteration of the biliary tract. Although little is known about the etiology or pathogenesis of biliary atresia, epidemiologic and virologic studies point to a complex trait disorder, in which environmental factors trigger an inflammatory process that recognizes and abnormally targets the biliary system during a specific phase of postnatal development. Regardless of initiating (environmental) and modifying (genetic) factors for disease development, the inflammatory and fibrosing destruction of the biliary epithelium is common to all clinical forms of biliary atresia. Portoenterostomy (Kasai procedure utilizing the intestine to make an artificial bile duct) is the only operative procedure used currently to improve bile drainage in infants with biliary atresia. Although prompt diagnosis and surgical intervention may induce bile flow, progression to end-stage liver disease occurs in over 50% of the patients by 2 years of age. In this setting, the potential decrease of this inflammatory component by corticosteroid treatment may result in improved bile flow and better outcome after portoenterostomy. We propose a multi-center randomized, double-blinded, placebo-controlled trial to prospectively determine the efficacy of corticosteroids on the outcome of infants with biliary atresia. The trial will be conducted by the NIDDK-funded network of nine clinical centers comprising the Biliary Atresia Clinical Research Consortium (BARC), whose goal is to study the etiology, pathogenesis, diagnosis, and treatment of infants with biliary atresia. Hypothesis: In this clinical trial we propose to objectively determine whether corticosteroid treatment improves bile flow in infants with biliary atresia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BCM/TCH CHOLESTATIC LIVER DISEASE CONSORTIUM
  • 批准号:
    10215815
  • 项目类别:
  • 资助金额:
    $25.5万
  • 财政年份:
    2014
  • 负责人:
    BENJAMIN L SHNEIDER
  • 依托单位:
BCM/TCH CHOLESTATIC LIVER DISEASE CONSORTIUM
  • 批准号:
    10019528
  • 项目类别:
  • 资助金额:
    $36.1万
  • 财政年份:
    2014
  • 负责人:
    BENJAMIN L SHNEIDER
  • 依托单位:
Clinical Center for ChiLDREN: Pathogenesis, Biomarkers, and Antifibrotic Therapy
  • 批准号:
    9552403
  • 项目类别:
  • 资助金额:
    $25.14万
  • 财政年份:
    2014
  • 负责人:
    BENJAMIN L SHNEIDER
  • 依托单位:
Clinical Center for ChiLDREN: Pathogenesis, Biomarkers, and Antifibrotic Therapy
  • 批准号:
    9135724
  • 项目类别:
  • 资助金额:
    $11.31万
  • 财政年份:
    2014
  • 负责人:
    BENJAMIN L SHNEIDER
  • 依托单位:
海外基金